Dexmeditomedine Vs Morphine infusion in term babies

Dexmeditomedine Vs Morphine infusion for sedation in mechanically ventilated Term Neonates - Dexmeditomedine Vs Morphine

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/01/030822

Enrollment

Registered

2021-01-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P285- Respiratory failure of newborn

Interventions

Intervention1: Dexmeditomedine infusion: Babies in this group will receive Inj. dexmeditomedine stat dose 0.5 micrograms/kg followed by infusion of 0.2 mics/kg/hr. All babies are assessed for pain and

Eligibility

Inclusion criteria

Inclusion criteria: All term neonates admitted in Neonatal Intensive care requiring Mechanical ventilation

Exclusion criteria

Exclusion criteria: Babies less 36 weeks of gestation, Term babies with Sarnat stage 2

Design outcomes

Primary

Measure	Time frame
Time to achieve pin relief in the first 24 hrs of commencing ventilation and hemodynamical stability during the study periodTimepoint: Time to achieve pin relief in the first 24 hrs of commencing ventilation and hemodynamical stability during the study period	—

Secondary

Measure	Time frame
hemodynamic instability interns of bradycardia and hypotension needing inotropesTimepoint: within 24 hrs	—

Countries

India

Contacts

Public ContactDrSushma Krishnegowda

JSS Medical College, JSS Academy of higher education and Research

drsushmasri@gmail.com9742299896

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026